Adopting New Technologies for Multiple Sclerosis Rehabilitation (Podcast)

A veteran clinician shares insights on the care-enhancing qualities of tech

“There’s a potentially large place for technology in multiple sclerosis [MS] rehabilitation, but we have to understand that it’s in partnership with the people who have MS and their families, who are the ones to decide how best it can help them.” That’s a takeaway shared by Francois Bethoux, MD, Director of Rehabilitation Services in Cleveland Clinic’s Mellen Center for Multiple Sclerosis, in the newest episode of Cleveland Clinic’s peer-to-peer Neuro Pathways podcast.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

In the podcast, Dr. Bethoux — who is also Chair of Cleveland Clinic’s Department of Physical Medicine and Rehabilitation, as well as Medical Director of its Arts & Medicine Institute — shares perspectives on the adoption of new technologies for MS rehabilitation. The discussion touches on a range of issues, including:

  • How MS rehabilitation has evolved over the past decade
  • The importance of patient affordability when considering rehab technology options
  • The role of rhythmic music in some patients’ rehab mix
  • The potential of powered exoskeletons for MS rehabilitation
  • What’s on the horizon in MS rehabilitation

Click the player below to listen to the 19-minute podcast now, or read on below for a short edited excerpt from the portion exploring powered exoskeletons. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

Excerpt from the podcast

Dr. Bethoux: The idea with the exoskeleton is to have a robotic brace, a brace that encapsulates the legs up to the hips and pelvis, and then motors that can activate the joints of the device to help the joints of the leg move, and a complex software that responds to what sensors can catch. If the person intends to make a step, they will move their body in such a way that if the sensor catches it, then it will trigger a step assisted by the device.

Advertisement

It’s a way to have a machine that interacts with the person and can interact with the environment. It has safety features to prevent falling, for example, and can enhance the person’s abilities. So if the person has weakness in the legs, then the machine can do some of the walking for the person. If they become more and more tired as they walk a longer distance, the machine can take over more and more, or vice versa. If they become stronger as they walk more, then the machine will provide less assistance. For example, if with training from session to session the person becomes more adept at walking, then we can provide less and less assistance until they can do their training without the machine.

The idea is that the machine is really not the end of it all, and that’s really what I’ve learned through research with almost any technology. The technology is an enabler or an enhancer. It’s something that allows people to perform exercise, rehabilitation or certain functions of life in an easier way. It doesn’t replace; it just enhances. But it can enhance in such a way that it makes a meaningful difference to the person.

Related Articles

23-NEU-3516858-brain-trauma-650×450
Neurotrauma Guidelines: Where They’ve Been, Where They’re Headed and How to Make the Most of Them

Q&A with Brain Trauma Foundation guideline architect Gregory Hawryluk, MD, PhD

20-NEU-2020111 neuroimmunology_650x450
Autoimmune Neurologic Disorders: Treatable Conditions That Should Not Be Missed

Q&A with newly arrived autoimmune neurology specialist Amy Kunchok, MD

20-NEU-1984276 multimodal-monitoring_650x450
Multimodal Monitoring in the Neuro ICU: Essentials for Clinicians (Podcast)

A neurocritical care specialist shares what’s spurring growth of this new evaluation approach

central vein sign in multiple sclerosis
New Frontiers in Diagnosing and Monitoring Multiple Sclerosis (Podcast)

Get ready for central vein sign and optical coherence tomography

20-NEU-1938374-migraine_650x450
CGRP Antagonists for Decreasing Migraine Frequency: A Primer

How these new drugs fit into practice two years out from their first approvals

20-NEU-1892171 CQD_650x450_CCC-1901608_06-03-20_0443
What’s Afoot and What’s Ahead for Physical Medicine and Rehabilitation

A conversation on the state of physiatry with the AAPM&R’s Vice President

Ad